Q1 2020 Biotec Pharmacon ASA Earnings Call Transcript
Okay. Welcome to the Q1 presentation. Before we kick off and go through things, just some practical things. Of course, this is a bit different to usual. So we've -- since we're all in home office and can't meet together, we're doing this by video teleconference. And so what I would kindly ask is that you ensure that you have your microphones muted. This will help to reduce background noise. And if you are sharing your video, please turn that off because it helps us have the best bandwidth to prevent dropouts during the presentation.
So today, it's myself, Jethro Holter, now the permanent CEO of Biotec Pharmacon; and we have Børge Sørvoll, our CFO, who will join us in -- late in the presentation. So for those of you who are not watching the stream live, I will tell you which slide number on, so we're going on to Slide #2, the agenda.
So in terms of the agenda today, what I'm going to do is we're going to walk you through the Q1 highlights. Then we're going to look at each of the businesses in turn, looking at ArcticZymes first, then Biotec
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |